IQYMUNE®▼ (Human normal immunoglobulin)

Adverse events should be reported. Reporting forms and information can be found at

Adverse events should also be reported to Medical Information, Pharmalex, Tel: 01628 531171

Job Code: 22/11/082 – Date of preparation: January 2023

IQYMUNE®▼ Human normal immunoglobulin (IVIg) solution for infusion 100 mg/mL

10% ready to use immunoglobulin

Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for IQYMUNE®▼.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.

By reporting side effects you can help provide more information on the safety of this medicine.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.